[1]
G. Ramya Priy et al. 2026. Concurrent validation of an active therapeutic molecule for Type II diabetes by Reverse Phase- High Performance Liquid Chromatography: A Quality Assessment Approach. The Bioscan. 21, 3 (Jul. 2026), 18–40.